JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB16058

Anti-MDMX/MDM4 antibody

3

(1 Review)

|

(11 Publications)

Rabbit Polyclonal MDMX/MDM4 antibody. Suitable for WB, ICC/IF and reacts with Human, Cow samples. Cited in 11 publications.

View Alternative Names

MDMX, MDM4, Protein Mdm4, Double minute 4 protein, Mdm2-like p53-binding protein, Protein Mdmx, p53-binding protein Mdm4

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-MDMX/MDM4 antibody (AB16058)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-MDMX/MDM4 antibody (AB16058)

ab16058 staining MDMX/MDM4 in HeLa cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab16058 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue). Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Western blot - Anti-MDMX/MDM4 antibody (AB16058)
  • WB

Unknown

Western blot - Anti-MDMX/MDM4 antibody (AB16058)

Two bands were detected with the antibody in HeLa nuclear extract, at ~80 and 100 kDa. The 80 kDa band was no longer detected after the addition of competing peptide, suggesting that this band corresponds to MDMX/MDM4. The 100 kDa band is not competed away by the addition of the immunizing peptide, suggesting that it is nonspecific cross-reactivity.

All lanes:

Western blot - Anti-MDMX/MDM4 antibody (ab16058) at 1/1000 dilution

Lane 1:

20ug calf thymus histone

Lane 2:

20ug HeLa nuclear extract

Lane 3:

20ug calf thymus histone with Human MDMX/MDM4 peptide (<a href='/en-us/products/unavailable/human-mdmxmdm4-peptide-ab16383'>ab16383</a>)

Lane 4:

20ug HeLa nuclear extract with Human MDMX/MDM4 peptide (<a href='/en-us/products/unavailable/human-mdmxmdm4-peptide-ab16383'>ab16383</a>)

Secondary

All lanes:

Alexa Fluor Goat polyclonal to Rabbit IgG (700) at 1/5000 dilution

Predicted band size: 55 kDa

Observed band size: 100 kDa,80 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Cow, Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Two bands were detected with the antibody in HeLa nuclear extract, at ~80 and 100 kDa. The 80 kDa band was no longer detected after the addition of competing peptide, suggesting that this band corresponds to MDMX/MDM4. MDMX/MDM4 has been shown previously to migrate aberrantly at an ~80 kDa size (see deGraaf, et.al., J Biol Chem. 2003 Oct 3;278(40):38315-24). The 100 kDa band is not competed away by the addition of the immunizing peptide, suggesting that it is nonspecific cross-reactivity.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The MDMX protein also known as MDM4 is an important regulator in the control of the p53 tumor suppressor pathway. Typically MDMX can be found expressed in multiple tissue types including the brain and kidney. MDMX with a molecular mass of approximately 54 kDa functions as an E3 ligase that binds to the p53 protein inhibiting its transcriptional activity and promoting its degradation. This precise interaction with p53 allows the regulation of cell growth and apoptosis making MDMX an important target for cancer research.
Biological function summary

MDMX contributes significantly to cell cycle regulation and apoptosis by forming a complex with MDM2 another E3 ubiquitin ligase. Together with MDM2 MDMX modulates the stability and activity of p53 therefore influencing cell fate decisions. This complex is important in preventing unwarranted p53 activity ensuring that the cell only undergoes apoptosis or cell cycle arrest in response to specific stress signals.

Pathways

The MDMX protein plays a central role in the p53 signaling pathway a critical mechanism in cellular response to genomic damage. It interacts directly with MDM2 to regulate p53's activity maintaining a balance between cell proliferation and death. This pathway is tightly linked to the DNA damage response providing a checkpoint during the cell cycle to prevent the propagation of genetically unstable cells. Additionally MDMX influences the PI3K/AKT pathway further intertwining its function with cellular survival processes.

The deregulation of MDMX is often associated with various forms of cancer including breast and colorectal cancers. Overexpression or genetic amplification of MDMX can lead to impaired p53 activity which promotes cell survival and proliferation in the presence of DNA damage. MDMX has a close connection with MDM2 in these disease contexts as both proteins synergize to inhibit p53 contributing to tumorigenesis. Therapeutic targeting of MDMX and its interaction with MDM2 offers a potential strategy for reinstating p53 activity in cancer treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Along with MDM2, contributes to TP53 regulation (PubMed : 32300648). Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions.
See full target information MDM4

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Cell biology international 46:2257-2261 PubMed35998257

2022

P53 in endothelial function and unfolded protein response regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Khadeja-Tul Kubra,Nektarios Barabutis

BioFactors (Oxford, England) 48:926-933 PubMed35266593

2022

Hsp90 inhibition protects brain endothelial cells against LPS-induced injury.

Applications

Unspecified application

Species

Unspecified reactive species

Mohammad A Uddin,Mohammad S Akhter,Khadeja-Tul Kubra,Nektarios Barabutis

Oncotarget 12:2131-2146 PubMed34676046

2021

Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumab.

Applications

Unspecified application

Species

Unspecified reactive species

Ilyas Sahin,Andrew George,Shengliang Zhang,Kelsey E Huntington,Zehra Ordulu,Lanlan Zhou,Wafik S El-Deiry

Nature 598:348-352 PubMed34552244

2021

Biologically informed deep neural network for prostate cancer discovery.

Applications

Unspecified application

Species

Unspecified reactive species

Haitham A Elmarakeby,Justin Hwang,Rand Arafeh,Jett Crowdis,Sydney Gang,David Liu,Saud H AlDubayan,Keyan Salari,Steven Kregel,Camden Richter,Taylor E Arnoff,Jihye Park,William C Hahn,Eliezer M Van Allen

Journal of Cancer 11:25-40 PubMed31892970

2020

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yangwei Fan,Ke Ma,Jiayu Jing,Chuying Wang,Yuan Hu,Yu Shi,Enxiao Li,Qianqian Geng

Cancer biology & therapy 20:617-632 PubMed30462562

2018

Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yangwei Fan,Mengya Li,Ke Ma,Yuan Hu,Jiayu Jing,Yu Shi,Enxiao Li,Danfeng Dong

Molecular medicine reports 17:2384-2392 PubMed29207086

2017

Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yukun Zu,Jianning Wang,Wei Ping,Wei Sun

Scientific reports 6:19004 PubMed26743233

2016

CPUY201112, a novel synthetic small-molecule compound and inhibitor of heat shock protein Hsp90, induces p53-mediated apoptosis in MCF-7 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Li Xu,Qi-chao Bao,Jian-Min Jia,Fang Liu,Xiao-Ke Guo,Ming-ye Zhang,Jin-lian Wei,Meng-chen Lu,Li-li Xu,Xiao-Jin Zhang,Qi-Dong You,Hao-Peng Sun

Oncotarget 5:10830-9 PubMed25350970

2014

A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways.

Applications

WB

Species

Unspecified reactive species

Chunlin Zhuang,Chunquan Sheng,Woo Shik Shin,Yuelin Wu,Jin Li,Jianzhong Yao,Guoqiang Dong,Wen Zhang,Yuk Yin Sham,Zhenyuan Miao,Wannian Zhang

Chemical biology & drug design 85:411-7 PubMed25226874

2014

A fluorescent probe for imaging p53-MDM2 protein-protein interaction.

Applications

WB

Species

Human

Zhenzhen Liu,Zhenyuan Miao,Jin Li,Kun Fang,Chunlin Zhuang,Lupei Du,Chunquan Sheng,Minyong Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com